Testosterone-focused men’s health pharma company Clarus Therapeutics (Clarus Therapeutics Stock Quote, Charts, News, Analysts, Financials OTC:CRXT) has had its share price hovering below the $0.10 per share mark for a while now. But with the immanent commercial launch of its Jatenzo testosterone capsules, the stock could be ready to rise. Based in Northbrook, Illinois, Clarus […]
Ginkgo Bioworks is a Buy, says Raymond JamesThe stock has fallen hard over the past couple of years, but Raymond James Financial analyst Rahul Sarugaser is staying optimistic on Ginkgo Bioworks (DNA Stock Quote, Charts, News, Analysts, Financials NYSE:DNA), saying in a Friday report to clients that it’s still early innings for the cell design company. Boston-based Ginkgo Bioworks reported its first […]